Health & Fitness
Health and Fitness
Health and Fitness
Wed, January 28, 2009
Tue, January 27, 2009 Life Technologies Wins Verdict on its SOLiD" Sequencing System
CARLSBAD, Calif.--([ BUSINESS WIRE ])--(NASDAQ:LIFE) announced today that a jury in the U.S. District Court for the Northern District of California rendered a verdict in its favor in its patent-infringement dispute with Illumina, Inc.
In this dispute, Illumina alleged that the SOLiD™ sequencing system commercialized by Applied Biosystems, a subsidiary of Life Technologies, infringed three patents, namely U.S. Patent Nos. 5,969,119; 5,750,341; and 6,306,597. The Court in this action previously ruled that the SOLiD™ system did not infringe two of the three patents and the jury was tasked with deciding whether Applied Biosystems' SOLiD™ technology infringed U.S. Patent No. 5,969,119 (the ‘119 patent) and whether this patent was valid.
After a seven day jury trial, the jury unanimously decided that the SOLiD™ sequencing technology did not infringe the ‘119 patent.
"We are very pleased with the decisions by the Court and the jury in this action," said Kip Miller, President, Genetic Systems Division at Life Technologies. "The SOLiD™ sequencing platform was developed through substantial R&D efforts within Applied Biosystems. These decisions validate our belief that the SOLiD™ sequencing system is unique in its design and paves the way for us to continue building on its innovative design and superlative performance with the upcoming launch of SOLiD 3.0 this February."
About Life Technologies
Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company has historical sales of approximately $3.5 billion, employs 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of over 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website [ www.lifetechnologies.com ]
Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
